Mikolaj Stachurski
Phd Student
E-mail: mikolaj.stachurski@ki.se
Visiting address: Hälsovägen, Enheten för öron-,näs och halssjukdomar B61, 14186 Stockholm
Postal address: H9 Klinisk vetenskap, intervention och teknik, H9 CLINTEC Öron näs o halssjukd, 141 52 Huddinge
About me
MD, ENT specialist and Director of Studies for Specialist Training in Otorhinolaryngology at the Department of Otorhinolaryngology, Östersund Hospital, Östersund, Sweden.
Member of the SweChole research team.
Research
My main research focus is middle ear cholesteatoma, with a particular interest in its epidemiological and clinical aspects, which form the basis of my PhD studies. I conduct my doctoral research at the Division of CLINTEC, Department of Ear, Nose and Throat Diseases, Karolinska Institutet, Stockholm, Sweden.
As a PhD student, I am a member of the SweChole research team, a national multicenter collaboration examining middle ear cholesteatoma in Sweden from multiple perspectives.
Articles
- Article: ACTA OTO-LARYNGOLOGICA. 2023;143(8):662-668The impact of waiting time on hearing outcome and patients' satisfaction after cholesteatoma surgeryStachurski M; Eriksson PO; Westman E; Mogensen H; Bonnard A
Grants
- Risk for pulmonary embolism and deep vein thrombosis following middle ear cholesteatoma surgeryRegion Jämtland Härjedalen1 January 2026 - 31 December 2026Background: Venous thromboembolic events (VTE), such as deep vein thrombosis (DVT) and pulmonary embolism (PE), are serious surgical complications with potentially fatal outcomes. The average annual incidence of VTE in Sweden between 2008 and 2018 was 231.3 per 100,000 inhabitants. Cholesteatoma surgery of the middle ear, which often lasts several hours, may promote thrombus formation through blood flow stasis during general anesthesia as well as local inflammation and vascular injury. There are no previous studies investigating the risk of VTE associated with this type of surgery. Aim: To estimate the risk of DVT, PE, and postoperative mortality following cholesteatoma surgery. Methods: All patients who underwent surgery in Sweden between 1987 and 2018 will be identified through the National Patient Register using ICD-9 and ICD-10 diagnosis codes and KVÅ procedure codes. VTE diagnoses, comorbidities (previous VTE, diabetes, hypertension, ischemic disease, arterial embolism, arrhythmia, and coagulopathies), and dates of death will be extracted. Two controls, matched for sex, age, and county of residence, will be linked to each case. Expected Results: We expect an increased risk of VTE following cholesteatoma surgery compared with the general population. Relevance: This study will contribute to increased knowledge of postoperative risks in otologic surgery. The results may form the basis for improved preoperative risk assessment and better thromboprophylaxis routines in Region Jämtland Härjedalen. The insights generated may also be valuable at a national level and used to inform the development of guidelines for otologic surgery throughout Sweden.